“We are going to evaluate how the commercialization of the substance suits in with our organization product at Adastra in order to posture ourselves to assist the demand from customers for a safe provide of copyright,” claimed Main executive officer Michael Forbes in a information launch. The company advised VICE News it wouldn't be commenting